| Christopher T King, DO | |
|
4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 | |
| (702) 653-3800 | |
| Not Available |
| Full Name | Christopher T King |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 4700 Las Vegas Blvd N, Nellis Afb, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376084012 | NPI | - | NPPES |
| Entity Name | Dignity Health Medical Group Nevada Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376805416 PECOS PAC ID: 1254571896 Enrollment ID: O20130703000051 |
News Archive
Complex biologics development and manufacturing specialist ProBioGen today announced that an investigational vaccine against Ebola virus disease, produced on its proprietary, continuous muscovy duck AGE1.CR.pIX cell line, has proceeded into clinical trials at the Jenner Institute, Oxford University, UK.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection, a new study led by Children's National Hospital researchers shows.
Patients, families and caregivers are invited to attend an educational conference covering many aspects of brain tumors May 14 at Cedars-Sinai Medical Center.
› Verified 1 days ago
| Entity Name | Nevada Acute Medical Services-scherr 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992244438 PECOS PAC ID: 6103101738 Enrollment ID: O20170322002944 |
News Archive
Complex biologics development and manufacturing specialist ProBioGen today announced that an investigational vaccine against Ebola virus disease, produced on its proprietary, continuous muscovy duck AGE1.CR.pIX cell line, has proceeded into clinical trials at the Jenner Institute, Oxford University, UK.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection, a new study led by Children's National Hospital researchers shows.
Patients, families and caregivers are invited to attend an educational conference covering many aspects of brain tumors May 14 at Cedars-Sinai Medical Center.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher T King, DO 4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 Ph: (702) 653-3800 | Christopher T King, DO 4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 Ph: (702) 653-3800 |
News Archive
Complex biologics development and manufacturing specialist ProBioGen today announced that an investigational vaccine against Ebola virus disease, produced on its proprietary, continuous muscovy duck AGE1.CR.pIX cell line, has proceeded into clinical trials at the Jenner Institute, Oxford University, UK.
Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the "Company") received a letter (the "Staff Determination") from the Nasdaq Stock Market ("NASDAQ") notifying the Company that, based upon the Company's non-compliance with the $10 million stockholders' equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company's securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "NASDAQ Panel").
Minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection, a new study led by Children's National Hospital researchers shows.
Patients, families and caregivers are invited to attend an educational conference covering many aspects of brain tumors May 14 at Cedars-Sinai Medical Center.
› Verified 1 days ago